mounjaro vs other glp 1 GLP-1 Medications for Weight Loss: Semaglutide Tirzepatide vs Retat – Revolution Health & Wellness Could GLP-1 Weight Loss Drugs
Description
LIPID MANAGEMENT 17
Its ideal for people who are on the go or prefer a no-needle protocol while still accessing next-generation peptide therapy
The future holds promise, including new medications, expanded indications, and greater affordability, but the rapid evolution of obesity management makes it difficult for organizations who assess benefits annually
The weight loss and diabetes drug market is being reshaped by GLP-1-based therapies, led by Novo Nordisk's Ozempic Registered and Wegovy Registered and Eli Lilly's Mounjaro Registered (Zepbound for obesity)
At present, the HSE reimburses liraglutide up to the dose of 1.8 mg
